» Articles » PMID: 12672806

Species-specific Regulation of Toll-like Receptor 3 Genes in Men and Mice

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Apr 4
PMID 12672806
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Toll-like receptor 3 (TLR3) belongs to a family of evolutionary conserved innate immune recognition molecules and recognizes double-stranded RNA, a molecular pattern associated with viral infections. Earlier studies suggested a differential expression pattern in men and mice; the molecular basis for this observation, however, was unknown. Here we demonstrate that species-specific differences in tissue expression and responses to lipopolysaccaride (LPS) coincide with the presence of different, evolutionary non-conserved promoter sequences in both species. Despite the overall unrelatedness of TLR3 promoter sequences, mRNA expression of both TLR3 orthologues was induced by interferons, particularly by interferon (IFN)-beta. The basal and IFN-beta-induced activation of promoters from both species largely depended on similar interferon regulatory factor (IRF) elements, which constitutively bound IRF-2 and recruited IRF-1 after stimulation. In murine macrophages, IFN-beta-induced TLR3 up-regulation required IFNAR1, STAT1, and in part IRF-1, but not the Janus kinase (Jak) family member Tyk2. We also show that LPS specifically up-regulates TLR3 expression in murine cells through the induction of autocrine/paracrine IFN-beta. In humans, however, IFN-beta-induced up-regulation of TLR3 was blocked by pretreatment with LPS, despite the efficient induction of IRF-1. Our findings reveal a mechanistic basis for the observed differences as well as similarities in TLR3 expression in men and mice. The IFN-beta-TLR3 link further suggests a role of TLR3 in innate and adaptive immune responses to viral infections. It will be interesting and important to clarify whether the observed differences in the transcriptional regulation of TLR3 influence innate immune responses in a species-specific manner.

Citing Articles

Toll-like receptor 3: a double-edged sword.

Hsieh M, Nishizaki D, Adashek J, Kato S, Kurzrock R Biomark Res. 2025; 13(1):32.

PMID: 39988665 PMC: 11849352. DOI: 10.1186/s40364-025-00739-5.


De novo design of protein minibinder agonists of TLR3.

Adams C, Kim H, Burtner A, Lee D, Dobbins C, Criswell C Nat Commun. 2025; 16(1):1234.

PMID: 39890776 PMC: 11785957. DOI: 10.1038/s41467-025-56369-w.


Therapeutic potential of targeting the IRF2/POSTN/Notch1 axis in nucleus pulposus cells for intervertebral disc degeneration.

Zhu D, Wang Z, Chen S, Li Y, Kang X J Neuroinflammation. 2025; 22(1):13.

PMID: 39844302 PMC: 11755837. DOI: 10.1186/s12974-025-03335-4.


Pig Milk Exosome Packaging ssc-miR-22-3p Alleviates Pig Intestinal Epithelial Cell Injury and Inflammatory Response by Targeting .

Li J, Hu H, Fu P, Yang Q, Wang P, Gao X Int J Mol Sci. 2024; 25(19).

PMID: 39409044 PMC: 11476862. DOI: 10.3390/ijms251910715.


Comparative network-based analysis of toll-like receptor agonist, L-pampo signaling pathways in immune and cancer cells.

Park S, Kim G, Choi A, Kim S, Yum J, Chun E Sci Rep. 2024; 14(1):17173.

PMID: 39060412 PMC: 11282102. DOI: 10.1038/s41598-024-67000-1.